Primary hyperaldosteronism sensitive to glucocorticoid treatment
Keywords:
arterial hypertenslon, glucocorticolds, ambuJatory blood pressure monitorlngAbstract
The autors describe the clinical case of a female patient with arterial hypertension, secondary to primary hyperaldosteronism, which proved to be sensitive to treatment with glucocorticoid steroids. Emphasis is placed on the sequence of complementary tests which lead to the final diagnosis, as well the contribuition that ambulatory blood pressure monitoring had, in the process of diagnostic evaluation and efficient therapeuthic control.
Downloads
References
MacMahon S, Peto R, Cutler J et al. Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression of dilution bias. Lancet 1990; 335: 765-774.
MacMahon S, Rodgers A. The effect of antihypertensive treatement on vascular disease: reappraisal of evidence in 1994. Trends Vasc Med 1994; 4(5-6): 265-271.
William F Youhg Jr, Michael]. Hogan., George G. Klee, Clives S. Grant, Jon A.van Heerden Primary aldosteronism: Diagnosis and Treatment.Ch.B. Mayo Clin Proc 1990; 65 :96-110.
Sutherland DJ, Ruse JL, Laidlaw JC. Hypertension, increased al dosterone secretion and low plasma renin activity relieved hy dexamethasone. An Md Asco J 1966;95:1109-1119.
Kaplan,. Burton D Rose New MI, Paternos RE. A Ne form. of congenial adrenal hiperplasia. J Clin Endocrinol Metab. 1967;27:300-305.
Rich GM, Ulick S, et al. Glucocorticoid-remediable aldosteronism in a large kindred: Clinical spectrum and diagnosis using a characteristic biochemical phenotype. Ann Intern Med 1992; 116:813.
Lifton RP, Dluhy RG, Powers M, et al. A chimeric 11 B-hydro xylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355:262.
Lifton RP, Dluhy RG, Powers M, et al. Hereditary hypertension caused by chimaeric gene duplications and expression of aldosterone synthase. Nat Genet 1992; 2:66.
Up To Date in Medicine: Glucocorticoid-remediable hyperaldosteronism. Kaplan NM, Rose BD. 1997; 5:1.
C.R.W. Edwards .Adrenalcortical Diseases.Oxford Textbook of Medicine. Third Edition 1996:1639-1663.
Glenn M. Rich, MD; Stanley Ulick, MD; Sandr,1 Cook, RN;Jennifer Z.Wang, MA; Richard P. Llfton, MD, PhD; and Robert G. Dluhy, MD. Glucocorticoid-remediable Aldosteronism in a Large Kindred: Clinicai Spectrum and Diagnosis Using a Characteristic Biochemical Phenotype. Ann Inter Med 1992; 116: 813-820
New MI, Borelli P, eds. Dexamethasone-Suppressible Hiperaldosteronism. Serono Symposia 10. Rome, Italy: Ares: Serono Symposia Via Ravenna; 1986
Ulick S. Two uncommon causes of mineralocorticoid excess. Endoc Metab Clin North Am 1991;20:269-276.
P.- F. Plouin, G. Chatellier, T.-T. Guyene, N. Vicent, P. Corvo!. Progres Récents dans l
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
